Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Katsurada K, Nakata M, Saito T, et al
The specific indicators of this improvement were: increased cardiac output, stroke volume, and peripheral muscle oxygenation
Using CATE values to divide the combined study cohorts with estimator information (46,394 individuals) into sub-cohorts revealed that those with a greater estimated glycemic advantage with glucagon-lile-peptide-1 receptor agonists over SGLT2 inhibitors were predominantly older and female, with lower initial HbA1c, body mass index (BMI), and estimated glomerular filtration rate (eGFR)
C.McLendonC.ShojiM.KawarabayashiT.et al (2002)
US$ 24.95
US$ 24.13
US$ 24.60
US$ 26.17
US$ 23.92
US$ 27.09
